Literature DB >> 16616888

Influence of N-acylation of a peptide derived from human lactoferricin on membrane selectivity.

Dagmar Zweytick1, Georg Pabst, Peter M Abuja, Alexander Jilek, Sylvie E Blondelle, Jörg Andrä, Roman Jerala, Daniel Monreal, Guillermo Martinez de Tejada, Karl Lohner.   

Abstract

Increasing numbers of bacterial strains being resistant to conventional antibiotics emphasize the urgent need for new antimicrobial agents. One strategy is based on host defence peptides that can be found in every organism including humans. We have studied the antimicrobial peptide LF11, derived from the pepsin cleavage product of human lactoferrin, known for its antimicrobial and lipid A-binding activity, and peptide C12LF11, the N-lauryl-derivative of LF11, which has owing to the attached hydrocarbon chain an additional hydrophobic segment. The influence of this hydrocarbon chain on membrane selectivity was studied using model membranes composed of dipalmitoylphosphatidylglycerol (DPPG), mimicking bacterial plasma membranes, and of dipalmitoylphosphatidylcholine (DPPC), a model system for mammalian membranes. A variety of biophysical techniques was applied. Thereby, we found that LF11 did not affect DPPC bilayers and showed only moderate effects on DPPG membranes in accordance with its non-hemolytic and weak antimicrobial activity. In contrast, the introduction of the N-lauryl group caused significant changes in the phase behaviour and lipid chain packing in both model membrane systems. These findings correlate with the in vitro tests on methicillin resistant S. aureus, E. coli, P. aeruginosa and human red blood cells, showing increased biological activity of C12LF11 towards these test organisms. This provides evidence that both electrostatic and hydrophobic interactions are crucial for biological activity of antimicrobial peptides, whereas a certain balance between the two components has to be kept, in order not to loose the specificity for bacterial membranes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616888     DOI: 10.1016/j.bbamem.2006.02.032

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

1.  Studies on lactoferricin-derived Escherichia coli membrane-active peptides reveal differences in the mechanism of N-acylated versus nonacylated peptides.

Authors:  Dagmar Zweytick; Günter Deutsch; Jörg Andrä; Sylvie E Blondelle; Ekkehard Vollmer; Roman Jerala; Karl Lohner
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

2.  Probing the "charge cluster mechanism" in amphipathic helical cationic antimicrobial peptides.

Authors:  Raquel F Epand; W Lee Maloy; Ayyalusamy Ramamoorthy; Richard M Epand
Journal:  Biochemistry       Date:  2010-05-18       Impact factor: 3.162

3.  Membrane binding of an acyl-lactoferricin B antimicrobial peptide from solid-state NMR experiments and molecular dynamics simulations.

Authors:  Tod D Romo; Laura A Bradney; Denise V Greathouse; Alan Grossfield
Journal:  Biochim Biophys Acta       Date:  2011-04-06

4.  Membrane-targeted synergistic activity of docosahexaenoic acid and lysozyme against Pseudomonas aeruginosa.

Authors:  Jose G Martinez; Michael Waldon; Qiyu Huang; Sandra Alvarez; Ami Oren; Natalie Sandoval; Ming Du; Feimeng Zhou; Alexandra Zenz; Karl Lohner; Robert Desharnais; Edith Porter
Journal:  Biochem J       Date:  2009-04-01       Impact factor: 3.857

5.  Effect of membrane composition on antimicrobial peptides aurein 2.2 and 2.3 from Australian southern bell frogs.

Authors:  John T J Cheng; John D Hale; Melissa Elliot; Robert E W Hancock; Suzana K Straus
Journal:  Biophys J       Date:  2009-01       Impact factor: 4.033

Review 6.  Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs.

Authors:  Sabrina Riedl; Dagmar Zweytick; Karl Lohner
Journal:  Chem Phys Lipids       Date:  2011-09-16       Impact factor: 3.329

7.  Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms.

Authors:  Susana Sánchez-Gómez; Raquel Ferrer-Espada; Philip S Stewart; Betsey Pitts; Karl Lohner; Guillermo Martínez de Tejada
Journal:  BMC Microbiol       Date:  2015-07-07       Impact factor: 3.605

8.  Influence of Dimerization of Lipopeptide Laur-Orn-Orn-Cys-NH2 and an N-terminal Peptide of Human Lactoferricin on Biological Activity.

Authors:  Elżbieta Kamysz; Emilia Sikorska; Małgorzata Dawgul; Rafał Tyszkowski; Wojciech Kamysz
Journal:  Int J Pept Res Ther       Date:  2014-08-21       Impact factor: 1.931

9.  N-acylated peptides derived from human lactoferricin perturb organization of cardiolipin and phosphatidylethanolamine in cell membranes and induce defects in Escherichia coli cell division.

Authors:  Dagmar Zweytick; Bostjan Japelj; Eugenia Mileykovskaya; Mateja Zorko; William Dowhan; Sylvie E Blondelle; Sabrina Riedl; Roman Jerala; Karl Lohner
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

10.  Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine.

Authors:  Sabrina Riedl; Beate Rinner; Helmut Schaider; Karl Lohner; Dagmar Zweytick
Journal:  Biometals       Date:  2014-05-18       Impact factor: 2.949

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.